Drug Dependence
Red Flags — the dangers in dependence
| Red flag | Why dangerous | Action |
|---|---|---|
| Opioid overdose — reduced consciousness, pinpoint pupils, respiratory depression | Rapidly fatal; risk multiplied by alcohol/benzodiazepine co-use, and after detox/prison release (lost tolerance). | 999; naloxone; support airway/breathing; take-home naloxone & training for those at risk |
| Abrupt benzodiazepine/alcohol withdrawal — seizures, delirium | Life-threatening; never stop these abruptly. | Gradual tapered withdrawal; medically supported detox; do not stop abruptly |
| Active suicidality / severe mental illness | Markedly raised in substance dependence. | Urgent mental-health assessment; safety plan |
| Safeguarding — children/vulnerable dependents | Parental substance use can endanger children. | Safeguarding assessment per local procedures; support the family |
| Injecting complications — abscess, DVT, endocarditis, BBV | Serious infection/thrombosis; transmissible disease. | Treat/admit as needed; BBV testing & vaccination; harm reduction |
| Paracetamol excess — extra co-codamol bought online on top of prescribed doses | Supratherapeutic or staggered paracetamol ingestion can cause liver failure with few early symptoms; alcohol and poor nutrition add risk. | Calculate total intake today; TOXBASE advice; same-day hospital assessment if above the daily maximum; LFTs |
| Tablets from online or street sources | Counterfeit tablets may contain nitazenes or other potent synthetic opioids (OHID National Patient Safety Alert, July 2023; UK drug-checking findings). | Naloxone; never use alone; move to a single prescribed supply |
| Dangerous co-prescribing (opioid + benzodiazepine/gabapentinoid) | Additive respiratory depression and overdose. | Avoid; review & rationalise; controlled-drug governance |
🙇 Reducing shame
Reframe dependence accurately and kindly.
"This isn't a moral failing — your body has become dependent on a medicine you were prescribed. That happens to lots of people, and we can help you through it."🤝 "I won't cut you off"
Directly address the abandonment fear.
"I'm not going to stop your tablets suddenly and leave you struggling. We'll reduce slowly, together, at a pace you can manage — and I'll keep supporting you whatever happens."🆘 Harm reduction first
Safety doesn't depend on stopping.
"While we work on this, let's keep you safe — I'd like to talk about overdose, especially mixing with alcohol, and give you naloxone, a medicine that can reverse an overdose."👪 The children & the future
Frame help as protective, sensitively.
"Getting you well is good for you and your kids. I may need to involve some support around the family — not to take anything away, but to make sure everyone's okay and you've got help."- Judgmental/moralising tone; threatening to stop the drug abruptly
- Not assessing co-use (alcohol/benzodiazepines) / overdose risk / mood / self-harm
- Not considering safeguarding (dependent children)
- Confusing dependence with addiction; no shared plan
Same day / 999
Immediate- OverdoseReduced consciousness/respiratory depression → 999 + naloxone
- Dangerous withdrawalBenzodiazepine/alcohol seizures/delirium → medical support
- Acute suicidality / crisisUrgent mental-health assessment
Drug services
Refer/share care- Illicit/injecting/OSTSpecialist drug service; methadone/buprenorphine; harm reduction
- Complex/polydrug/pregnancyMultidisciplinary specialist
- Safeguarding concernsSafeguarding + drug service
Supported taper
With support- Prescribed opioid/benzo/gabapentinoid dependenceGradual taper + review (Dawn)
- Harm reductionNaloxone, overdose advice, BBV
- Treat mood & painAddress the drivers
- Missing overdose / dangerous-withdrawal risk
- Not involving specialist drug services when indicated
- No explicit risk formulation
- Not mapping all substances/alcohol
- Not offering BBV testing/vaccination where relevant
- Ignoring the alcohol assessment
🚩 Treat the person and the drivers, not just the drug
Dawn's formulation is iatrogenic opioid dependence with harmful alcohol co-use and low mood, in a mother of two, with raised overdose risk from the alcohol. The plan is a supported, gradual opioid taper (never abrupt), harm reduction with take-home naloxone and overdose/alcohol advice, treatment of her mood and a non-opioid approach to her chronic pain, safeguarding consideration for the children, and specialist drug-service support — delivered without stigma and with the door kept open.
- Labelling without addressing the drivers (pain/mood)
- Stigmatising language
- Not involving specialist services for complex/illicit use
- Not addressing safeguarding/mental health/pain
Validate — name the fear and the courage
Dawn has rehearsed the worst outcome: the tablets stopped today, a label of "addict" on her record, and social services at the door. She also half-hopes for the opposite — that the doctor will simply prescribe the extra so she no longer has to buy it online. Naming both expectations out loud, before any plan, stops her bracing for a fight and signals that you are on her side.
"I think you came in expecting me to stop your tablets, maybe tell you off, and perhaps involve social services. None of that is how this works. You've done exactly the right thing by coming, and I want to help you get back in control — safely."Explain — why slow, why one supply, why safety first
She needs three pieces of reasoning. First, stopping suddenly would make her unwell and push her back to buying online, so reduction is gradual. Second, buying co-codamol online is dangerous for reasons she may not know: the paracetamol in every tablet can silently damage the liver, especially with wine, and counterfeit tablets can contain far stronger synthetic opioids. Third, the codeine is not treating her back pain well — NICE NG59 advises against opioids for chronic low back pain — so the aim is better pain control by other means, not simply less medication.
"Your body has got used to codeine, so stopping suddenly would make you feel awful — we won't do that. What worries me more is the online tablets: each one has paracetamol, which can hurt your liver, especially with wine, and you can't be sure what's really in them. So step one is getting everything from one safe supply, then bringing it down slowly."Negotiate — give her something concrete today
She should leave with: an agreed prescribed dose from one prescriber, dispensed in small instalments; a take-home naloxone kit and a plan for who knows where it is; blood tests (LFTs, BBV offer); a referral or self-referral route to the local drug and alcohol service; a first step on the alcohol; help for her mood and sleep; and a review within a week. Safeguarding is discussed openly as support for the family, not as a threat.
"Here's what I suggest for today: I'll prescribe what you need from one place, a week at a time, so you don't need to buy any online. I'll give you naloxone to keep at home. I'll check your liver, and put you in touch with the drug and alcohol team — they're supportive, not punitive. Then I'll see you next week and we'll plan the first small reduction together. How does that sound?"Naloxone is a competitive opioid antagonist that displaces opioids from receptors and restores breathing within minutes. It is shorter-acting than most opioids, so re-sedation can occur — the person must never be left alone and 999 is always called.
Supply an intramuscular (Prenoxad) or intranasal (Nyxoid) kit with training — for Dawn and for whoever is at home. Drug services have been able to supply naloxone without a prescription since 2015, extended to all formulations including nasal by the Human Medicines (Amendment) Regulations 2019; 2024 regulations widened supply to more services and professionals. Replace kits used, lost or out of date.
Opioids, alcohol, benzodiazepines, z-drugs and gabapentinoids act synergistically on respiratory drive; most drug-poisoning deaths involve more than one depressant. Unregulated tablets may contain nitazenes, which can be many times more potent than the drug they imitate, and may need repeated naloxone doses.
Agree specific rules: no wine on the same evening as codeine while the alcohol plan starts; no tablets from anyone else; tell someone at home when she takes her dose; keep the naloxone visible. If she does use from an unknown source — a small test amount, never alone. Store all medicines locked away from the children.
About 9–10 units nightly adds to opioid respiratory depression, worsens sleep architecture and mood, and increases paracetamol hepatotoxicity. If she is alcohol-dependent, abrupt cessation risks withdrawal seizures — the same "never stop suddenly" rule applies as for benzodiazepines.
AUDIT; if dependence is possible, SADQ and withdrawal history. Non-dependent harmful drinking → brief intervention and a stepped reduction with drink-free days. Dependent → planned assisted withdrawal with the specialist service (NICE CG115 thresholds, as in the alcohol protocol) with thiamine. Tackle alcohol alongside the opioid, not "later".
Long-term opioids give little functional benefit in chronic low back pain and can cause opioid-induced hyperalgesia; as the dose falls, pain often stays the same or improves. Graded activity rebuilds tolerance to movement and reduces fear-avoidance.
Group or individual exercise programme via physiotherapy; manual therapy only as part of a package with exercise; support return to work. NICE NG59's psychological therapy and combined physical–psychological programme recommendations (1.2.13, 1.2.14) were withdrawn on 29 July 2026 — her mood and distress are supported through NHS Talking Therapies in their own right. Resources such as Live Well with Pain run alongside the taper.
Low mood, anxiety and insomnia are both causes and consequences of opioid and alcohol use, and withdrawal amplifies them temporarily. Motivational interviewing strengthens her own reasons for change; structured support improves retention and reduces relapse.
NHS Talking Therapies (self-referral) for depression/anxiety; CBT-I principles for sleep rather than a hypnotic; drug and alcohol service keyworking; mutual aid (SMART Recovery, Narcotics Anonymous) offered with facilitated access. Contingency management and behavioural couples therapy are CG51 options within specialist services.
Stable housing, income, relationships and meaningful activity ("recovery capital") predict sustained recovery. Parental substance use affects children through inconsistent care, secrecy and household risk — support for the parent is support for the children.
Explore who else is at home and who can help; offer early help or family support services; school nurse or health visitor liaison where appropriate; social prescribing for debt, benefits and activity. Follow local safeguarding procedures if there is risk of significant harm — openly, with Dawn wherever safe to do so.
One prescriber · one pharmacy · a verified, capped daily dose
- Calculate the real daily codeine and paracetamol intake (prescribed + bought), and her oral morphine equivalent
- Never prescribe paracetamol above the SPC maximum; codeine's SPC maximum is 240 mg/day — if her true intake exceeds what can be prescribed safely, do not try to match it: seek drug-service advice (buprenorphine substitution is a specialist option for codeine dependence)
- Consider switching co-codamol to a codeine-only preparation so the taper does not drag paracetamol with it; dose per SPC
- Dispense in instalments (weekly, or more often if risk is high); no early scripts; record an agreement
Individualised and proportional — e.g. about 5–10% of the current dose every 2–4 weeks; smaller steps at the end
- Agreed with Dawn; she sets the pace (NICE NG215: shared decision, patient-led, flexible)
- Hold at a step for a hard week or life event — do not reverse more than one step
- Pre-warn: withdrawal (sweats, yawning, cramps, diarrhoea, restlessness, anxiety) peaks within days of a cut and settles — it is not the back pain returning
- Symptomatic relief per SPC (e.g. loperamide for diarrhoea, an antiemetic); avoid adding benzodiazepines or gabapentinoids
- Review at least every 2–4 weeks; weekly at first
Loss of control, high intake, or the taper keeps failing
- Continued online or illicit buying despite a prescribed supply
- Intake above safe prescribable limits; injecting; heroin or other illicit opioids
- Repeated failed tapers; polydrug use; pregnancy; significant mental illness
- Specialist options: OST maintenance with buprenorphine or methadone (TA114), a planned detox (CG52), then relapse prevention with naltrexone for the motivated and opioid-free (TA115)
- Never stop abruptly after prolonged use — seizures, delirium and severe rebound anxiety or insomnia
- First consider tapering the current drug directly; switch to diazepam selectively (short half-life or high-potency drug, inter-dose withdrawal, or strengths too large for small steps). A reasonable starting point is about 5–10% of the current dose every 2–4 weeks at a pace the patient controls, with smaller steps near the end (NICE NG215)
- On a setback, delay or shrink the next step, or return to the previous tolerated dose; review every 1–2 weeks
- High-dose, illicit or multiple-source use, "street benzos" or polydrug dependence → specialist drug service — street supply may be counterfeit and contain nitazenes or novel benzodiazepines
- Never co-prescribe with opioids unless there is no alternative — lowest dose, shortest time, monitor for respiratory depression (MHRA DSU, March 2020)
- Gabapentin and pregabalin: Class C, Schedule 3 controlled drugs since 1 April 2019 — good practice is no more than 30 days' supply per prescription. The MHRA (January 2026) strengthened addiction, dependence and withdrawal warnings for gabapentinoids, benzodiazepines and z-drugs. Misused for euphoria and to potentiate opioids; in combination they add respiratory depression. Withdraw gradually (NICE NG215; per SPC) — do not stop abruptly
- Cocaine, crack, amphetamines: no substitute prescribing; psychosocial interventions including contingency management (CG51); warn about cardiac risk (cocaine chest pain → 999/emergency assessment) and the added toxicity of cocaine with alcohol
- Pregnancy: urgent joint drug service and maternity care; continue and stabilise OST — do not attempt abrupt detox; plan for neonatal abstinence syndrome; codeine is avoided in breastfeeding (MHRA)
"If someone can't be woken, is breathing slowly or has tiny pupils: call 999, give the naloxone, put them on their side, and stay with them — it can wear off before the drugs do. Keep it somewhere the family knows about, and come back for another if you use it or lose it."
SCA: offering naloxone to a patient with prescribed codeine dependence who drinks nightly is a high-value Tasks mark that many candidates miss because they think naloxone is only for heroin users.
"We'll bring this down in small steps you agree to. If a step feels too hard, we pause there. Please don't top up from anywhere else — if you're struggling, tell me and we'll adjust the plan rather than you having to buy tablets."
SCA: spotting the paracetamol risk hidden inside "extra co-codamol" is a discriminating Tasks point; so is not matching an unverified reported dose with a prescription.
"Methadone builds up over the first few days, so we go slowly even if it feels like it isn't enough yet. Never take extra, never mix it with alcohol or tablets, keep it locked away — a small amount can kill a child — and if you miss three days, come back before you take it again."
SCA: any new medicine for someone on methadone — antibiotic, antidepressant, antiemetic — prompts an interaction and QT check.
"You take the first dose when you're already feeling withdrawal — if you take it too soon it can make you feel worse, not better. Once you're settled, it holds off cravings and it's harder to overdose on than other opioids, though mixing with alcohol or tablets is still dangerous."
SCA: knowing why buprenorphine is started in withdrawal (partial agonist displacing a full agonist) shows genuine understanding rather than recall.
"We'll come down gradually at a pace you're comfortable with. Some withdrawal — poor sleep, jitteriness — is common and passes. Never stop suddenly on your own; that's the one thing that can be dangerous."
SCA: "never abrupt, patient-led, slow down or step back on a setback" is the three-part answer examiners look for in benzodiazepine dependence.
"Naltrexone stops opioids having any effect — so it removes the temptation, but it also means trying to override it with a large amount is extremely dangerous. And after a detox your body can't handle your old dose any more."
SCA: pairing any detox with naloxone and a warning about lost tolerance is the safety step that separates a pass from a strong pass.
Children and Safeguarding
Parental substance use is a recognised risk factor, but most parents in treatment keep their children. Safeguarding is proportionate: it asks whether the children are safe and supported now, and what help the family needs. Early help and honest partnership are the usual route; a referral to children's social care is made when there is reasonable concern of significant harm, following local procedures and Working Together to Safeguard Children 2026.
Practical risks to address today: medicines stored locked away; who looks after the children if she is unwell; no driving them while impaired.
"Coming for help is the most protective thing you could do for your children. My job is to make sure you and they have support. If I ever need to involve anyone else, I'll tell you first and explain why."Driving and DVLA
Driving while impaired by any drug, prescribed or not, is an offence; the drug-driving law gives a medical defence only if a prescribed medicine is taken as directed and the driver is not impaired. Persistent misuse of or dependence on opioids and other drugs is a notifiable condition for DVLA purposes (non-prescribed use, or doses above SPC limits, count as misuse or dependence for licensing): the patient must tell the DVLA, and the licence is usually refused or revoked for a minimum period of stability (longer for Group 2 lorry and bus licences). People fully compliant with a supervised methadone or buprenorphine programme may be licensed after favourable assessment, usually with annual review.
"I need to talk about driving. Please don't drive on any day you feel drowsy or have been drinking. Because of the dependence, the DVLA rules may also apply to you — let's look at them together so you know where you stand."Work, Money and the Online Habit
Buying co-codamol online costs money and time and carries the constant fear of being found out. Sick days for withdrawal or hangovers may be putting her job at risk. A fit note can say "may be fit for work" with adjustments during a difficult phase; the reason can be worded with her agreement. Debt advice and benefits checks via social prescribing reduce pressure that drives relapse.
"How has work been through all this? If there's a hard patch while we reduce, I can help with a fit note — and we can agree together what it says."Identity, Shame and Stigma
"Addict" is a word Dawn applies to herself as a verdict. Person-first language (a person with dependence, not "an addict"), accurate explanation of iatrogenic dependence, and acknowledgement of the courage it took to attend reduce shame — and shame reduction measurably improves engagement. Coding and records should be accurate but not pejorative.
"You're not 'an addict' — you're someone whose body has become dependent on a medicine that was prescribed for you. That's common, and it's treatable."Relationships and the Evening Wine
The nightly bottle may be her only "switch-off", or a shared habit with a partner. Cutting down can strain the relationship if the partner is not on board. Inviting a trusted person into the plan (with consent) helps with naloxone, supervision of medicines and support on hard evenings. Screen sensitively for domestic abuse, which is common and changes the plan.
"Is there someone at home you trust who could know about the plan? It helps to have someone who knows where the naloxone is and can support you on tough evenings."Relapse, Hope and Keeping the Door Open
Relapse is common and is part of recovery, not a reason to stop care. The dangerous moment after a lapse is shame-driven disappearance — or returning to an old dose after a break, when tolerance has fallen. An explicit agreement that she can come back at any point, without judgement, is a safety intervention in its own right.
"If you slip up — buy tablets again, or have a bad week — please come and tell me. You won't be in trouble, and the plan won't be torn up. We'll just adjust it."Today — Safety, Stabilisation and Engagement
Naloxone supplied and demonstrated; overdose and never-mix advice; total codeine and paracetamol intake calculated; one prescriber and instalment dispensing agreed; bloods requested (LFTs, FBC, U&E; BBV offered); AUDIT; PHQ-9 and suicide risk; safeguarding discussed openly; driving advice documented; drug and alcohol service referral or self-referral details given. If paracetamol intake has exceeded the daily maximum, act on it today (TOXBASE-guided; same-day hospital assessment if indicated).
1 Week — Stable Baseline?
Any online purchases since? Taking the prescribed dose only? Withdrawal symptoms? Blood results reviewed. Alcohol plan started (brief intervention, or SADQ and specialist plan if dependent). Mood and sleep; start treatment or Talking Therapies. Agree the taper schedule in writing if stable. Drug service appointment date?
Every 2–4 Weeks — Taper Reviews
One step at a time; hold if a step is hard. Check withdrawal versus pain; function goals; alcohol; mood and suicide risk; naloxone kit still present; children and home situation; physiotherapy and pain self-management progress. Watch for aberrant signs (early requests, lost scripts, new sources) and respond by adjusting supply and support, not by stopping abruptly.
3 Months — Direction of Travel
Is the taper progressing? If control is being lost, intake is rising or she is still buying online, move to specialist care (OST is a legitimate option). If progressing: continue, re-check LFTs if alcohol or paracetamol concerns, review PHQ-9 and AUDIT, confirm the family support plan and DVLA position.
End of Taper and Beyond — Relapse Prevention
Tolerance is now low: an overdose warning is essential — a return to her old dose could be fatal. Keep the naloxone. Continue pain self-management and mood treatment. Agree a no-blame re-entry route. At any future transition — hospital admission, a new prescriber, a new painful condition — flag the history so opioids are not restarted casually.
Memory rule — "NALOXONE" at every review
Naloxone kit present and in date · Alcohol and other sedatives · LFTs if paracetamol or alcohol excess · Opioid dose actually taken (and any other source) · X — cross-check the controlled-drug record for early requests or multiple prescribers · Overdose and suicide risk · Next step of the taper agreed · Everyone at home safe — children and safeguarding.
| Target / medicine | Test or check | Timing | Action threshold |
|---|---|---|---|
| Opioid taper (Dawn) | Dose taken vs prescribed; withdrawal symptoms; function | Weekly at first, then every 2–4 weeks | Buying elsewhere, escalating or repeated failed steps → specialist drug service; hold at current step if withdrawal significant |
| Paracetamol excess | Intake history; LFTs ± paracetamol level | Today if above maximum | Intake above the daily maximum → TOXBASE advice; same-day hospital assessment where indicated; never rely on normal LFTs alone |
| Alcohol | AUDIT; SADQ if dependent; LFTs, GGT, MCV | Baseline; each review | Dependence → planned assisted withdrawal with thiamine (NICE CG115); never advise abrupt stop |
| Mood & suicide risk | PHQ-9, GAD-7, direct risk questions | Every review | Active suicidal intent or plan → same-day crisis/mental health assessment; limit supply; involve family with consent |
| Methadone (OST) | ECG (QTc); electrolytes | Baseline where risk factors; with dose rises or new QT drugs | MHRA advice: ECG with risk factors or above 100 mg/day; prolonged QTc → specialist review, consider buprenorphine |
| Methadone (OST) | Pharmacy missed-dose report | Immediately | 3+ consecutive missed days → do not give usual dose; reassess and re-titrate |
| Buprenorphine / naltrexone | LFTs | Baseline, then periodically | Significant transaminase rise → specialist review |
| OST stability | Urine or oral-fluid drug testing | At initiation, then periodically | Negative for prescribed drug → possible diversion; positive for other opioids/benzodiazepines → overdose risk review, adjust supervision |
| Blood-borne viruses | HIV, hepatitis B (and immunity), hepatitis C antibody ± RNA | Baseline; repeat if ongoing risk (e.g. at least annually if injecting) | Non-immune to HBV → vaccinate (rapid 0, 7, 21-day schedule with a 12-month booster is an option — Green Book ch. 18); HCV positive → refer for curative treatment |
| Gabapentinoid / benzodiazepine | Dose, supply, co-prescribed opioid | Every script | Any combination with opioids → deprescribing priority; no more than 30 days' supply per script for Schedule 3 gabapentinoids (good practice) |
⚠ Three scenario-specific phrases — use these verbatim
What to document — every time
- Abrupt stopping; no harm reduction/naloxone
- Ignoring mood/pain drivers; no safeguarding
- Punitive stance; door closed on relapse
Who you are
Dawn Fletcher, 41, two school-age children. You've taken codeine/co-codamol for chronic back pain for years. You now take well above the prescribed dose, buy extra co-codamol online, and get anxious, sweaty and unwell if you run out — taking it more to stop the withdrawal than for the pain. You feel deeply ashamed, fear you're "an addict", and are terrified the doctor will simply stop your tablets and leave you in pain and withdrawal. Your mood is low, you sleep badly, and you drink about a bottle of wine most evenings. You've come, hesitantly, because a friend nearly died of an overdose and it frightened you.
Hidden concerns (reveal if explored)
Fear of being cut off (main): if the doctor reassures you they won't stop the tablets abruptly and won't judge you, you visibly relax and open up.
Shame: you think you're a bad person/mother; compassion helps hugely.
The alcohol: you'll admit the nightly wine if asked non-judgmentally.
The children: you worry about admitting struggles in case they're taken — needs sensitive handling.
Clinical details if asked
- Escalating codeine/co-codamol, non-prescribed online supplementation, withdrawal-driven use
- ~1 bottle of wine/evening; low mood, poor sleep; no current plan to harm yourself but life feels hard
- Two dependent children at home; you're the main carer; no injecting; oral use only
- Chronic low back pain (the original reason); opioids don't really help it much now
- Frightened after a friend's near-fatal overdose; never had naloxone or overdose advice
Reactions at key moments
- If judged or told tablets stop now: you become distressed, defensive, and likely to leave/conceal.
- On "I won't cut you off, we'll reduce slowly together": relief, tearful, engaged.
- On naloxone/overdose advice (esp. with alcohol): you take it seriously after your friend's experience.
- On safeguarding mentioned supportively: anxious but reassured it's about help, not removal.
- Challenge line: "You're going to take my tablets away and report me, aren't you?"
Resolution: Dawn engages if the GP: (1) responds with warmth and non-judgmental, person-first language, explicitly reassuring her they won't stop her medication abruptly or abandon her, and reframing iatrogenic dependence as common and treatable rather than a moral failing; (2) assesses co-use (the nightly alcohol — raising overdose and abrupt-withdrawal seizure risk), mood/self-harm, and the dependent children (safeguarding, framed supportively); (3) plans a supported, gradual taper (never abrupt), provides take-home naloxone and overdose/alcohol advice, and treats the drivers (mood and a non-opioid approach to the back pain); (4) works with specialist drug services and keeps the door open, treating relapse as part of recovery. She disengages if judged, threatened with abrupt stopping, or frightened about her children without support.
Recognise dependence (escalation, non-prescribed sources, withdrawal-driven use); distinguish from addiction/tolerance. Assess co-use (alcohol/benzodiazepines → overdose & seizure risk), mood/self-harm, BBV/physical, social & safeguarding. Emergencies: overdose (999 + naloxone), dangerous withdrawal (benzo/alcohol seizures), acute suicidality.
Supported, GRADUAL taper — never abrupt. Harm reduction: take-home naloxone + training, overdose/alcohol advice, BBV testing/vaccination, needle exchange. OST (methadone/buprenorphine) for illicit opioid dependence (specialist). Avoid co-prescribing opioids + benzodiazepines/gabapentinoids. Treat drivers (mood; chronic low back pain non-opioid, NG59). Safeguarding for dependents. Non-judgmental; relapse = part of recovery; work with specialist services.